Hologic and Google Cloud Announce Collaboration to Advance Next Generation Digital Diagnostic Capabilities
February 01 2021 - 4:01PM
Business Wire
New agreement to focus on enhancing artificial
intelligence and machine learning to bring about breakthrough
results in cervical cancer screening
Hologic, Inc. (Nasdaq: HOLX) announced today a multi-year
strategic collaboration with Google Cloud that will feature the
integration of Google Cloud’s machine learning (ML) technologies
with Hologic’s cutting-edge Genius™ Digital Diagnostics System to
transform screening and accelerate the eradication of cervical
cancer across the globe.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20210201005885/en/
Genius Digital Diagnostics is the first digital cytology
platform to combine artificial intelligence (AI) with advanced
digital imaging to help identify pre-cancerous lesions and cancer
cells in women. Now, Hologic is enhancing the deep learning
component of the system with Google Cloud. The expectation is that
the Genius Digital Diagnostics System will derive even more
actionable insights from cytology slides for cytotechnologists and
pathologists. Google Cloud also provides a secure and reliable
cloud data architecture to further extend the system’s
capabilities.
“Hologic has been at the forefront of cervical cancer screening
for more than 30 years, and we are building on that legacy with
this strategic collaboration,” said Kevin Thornal, President of
Hologic’s Diagnostic Solutions Division. “Enhancing our use of AI
with Google Cloud’s machine learning capabilities and cloud
architecture is the next natural step in this journey forward.”
Hologic is conducting research to explore the meaningful
differences working at the intersection of AI and ML can have
within diagnostics, improving laboratory performance, healthcare
provider decision-making, and ultimately patient care.
“Through this collaboration with Hologic, we are helping to
evolve digital diagnostics by complementing their expertise in
diagnostics and AI with our expertise in machine learning,” said
Joe Miles, Managing Director of Google Cloud Healthcare and Life
Sciences. “We are further bringing to life our two organizations’
shared commitment to reimagining digital diagnostic capabilities
for laboratories and healthcare providers across the globe,
ultimately enabling them to better serve their patients.”
Genius Digital Diagnostics is CE-marked for diagnostic use in
Europe and is not available for sale in the United States.
Financial terms of the collaboration were not disclosed.
About Hologic
Hologic, Inc. is an innovative medical technology company
primarily focused on improving women’s health and well-being
through early detection and treatment. For more information on
Hologic, visit www.hologic.com.
Hologic Forward-Looking Statements
This press release may contain forward-looking information that
involves risks and uncertainties, including statements about the
use of Hologic’s diagnostic products. There can be no assurance
these products will achieve the benefits described herein or that
such benefits will be replicated in any particular manner with
respect to an individual patient. The actual effect of the use of
the products can only be determined on a case-by-case basis
depending on the particular circumstances and patient in question.
In addition, there can be no assurance that these products will be
commercially successful or achieve any expected level of sales.
Hologic expressly disclaims any obligation or undertaking to
release publicly any updates or revisions to any such statements
presented herein to reflect any change in expectations or any
change in events, conditions or circumstances on which any such
statements are based.
Hologic, Genius and The Science of Sure are registered
trademarks of Hologic, Inc. in the United States and/or other
countries.
Source: Hologic, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210201005885/en/
Media Contact: Jane Mazur 508.263.8764 (direct)
585.355.5978 (mobile) jane.mazur@hologic.com
Investor Contact: Michael Watts 858.410.8588
michael.watts@hologic.com
Hologic (NASDAQ:HOLX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Hologic (NASDAQ:HOLX)
Historical Stock Chart
From Apr 2023 to Apr 2024